493 related articles for article (PubMed ID: 15246848)
1. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
Shults CW; Flint Beal M; Song D; Fontaine D
Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.
; Hyson HC; Kieburtz K; Shoulson I; McDermott M; Ravina B; de Blieck EA; Cudkowicz ME; Ferrante RJ; Como P; Frank S; Zimmerman C; Cudkowicz ME; Ferrante K; Newhall K; Jennings D; Kelsey T; Walker F; Hunt V; Daigneault S; Goldstein M; Weber J; Watts A; Beal MF; Browne SE; Metakis LJ
Mov Disord; 2010 Sep; 25(12):1924-8. PubMed ID: 20669312
[TBL] [Abstract][Full Text] [Related]
3. The effect of coenzyme Q10 therapy in Parkinson disease could be symptomatic.
Horstink MW; van Engelen BG
Arch Neurol; 2003 Aug; 60(8):1170-2; author reply 1172-3. PubMed ID: 12925381
[No Abstract] [Full Text] [Related]
4. Redox status of plasma coenzyme Q10 indicates elevated systemic oxidative stress in Parkinson's disease.
Sohmiya M; Tanaka M; Tak NW; Yanagisawa M; Tanino Y; Suzuki Y; Okamoto K; Yamamoto Y
J Neurol Sci; 2004 Aug; 223(2):161-6. PubMed ID: 15337618
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 in early Parkinson disease.
Hunter DA
Arch Neurol; 2003 Aug; 60(8):1170; author reply 1172-3. PubMed ID: 12925382
[No Abstract] [Full Text] [Related]
6. [Effect of coenzyme Q10 in patients with kidney diseases].
Gazdíková K; Gvozdjáková A; Kucharská J; Spustová V; Braunová Z; Dzúrik R
Cas Lek Cesk; 2001 May; 140(10):307-10. PubMed ID: 11411060
[TBL] [Abstract][Full Text] [Related]
7. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
Ferrante KL; Shefner J; Zhang H; Betensky R; O'Brien M; Yu H; Fantasia M; Taft J; Beal MF; Traynor B; Newhall K; Donofrio P; Caress J; Ashburn C; Freiberg B; O'Neill C; Paladenech C; Walker T; Pestronk A; Abrams B; Florence J; Renna R; Schierbecker J; Malkus B; Cudkowicz M
Neurology; 2005 Dec; 65(11):1834-6. PubMed ID: 16344537
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q10.
Bonakdar RA; Guarneri E
Am Fam Physician; 2005 Sep; 72(6):1065-70. PubMed ID: 16190504
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of coenzyme Q10 in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; de Bustos F; García-Redondo A; Gómez-Escalonilla C; Martínez-Salio A; Berbel A; Camacho A; Zurdo M; Barcenilla B; Enríquez de Salamanca R; Arenas J
J Neural Transm (Vienna); 2000; 107(2):177-81. PubMed ID: 10847558
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial.
Miles MV; Patterson BJ; Schapiro MB; Hickey FJ; Chalfonte-Evans M; Horn PS; Hotze SL
Pediatr Neurol; 2006 Jul; 35(1):30-7. PubMed ID: 16814082
[TBL] [Abstract][Full Text] [Related]
13. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial.
Ikematsu H; Nakamura K; Harashima S; Fujii K; Fukutomi N
Regul Toxicol Pharmacol; 2006 Apr; 44(3):212-8. PubMed ID: 16431002
[TBL] [Abstract][Full Text] [Related]
14. Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in parkinsonian patients.
Shults CW; Beal MF; Fontaine D; Nakano K; Haas RH
Neurology; 1998 Mar; 50(3):793-5. PubMed ID: 9521279
[TBL] [Abstract][Full Text] [Related]
15. Serum cholesterol levels and the risk of Parkinson's disease.
de Lau LM; Koudstaal PJ; Hofman A; Breteler MM
Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642
[TBL] [Abstract][Full Text] [Related]
16. Assessment of coenzyme Q10 tolerability in Huntington's disease.
Feigin A; Kieburtz K; Como P; Hickey C; Claude K; Abwender D; Zimmerman C; Steinberg K; Shoulson I
Mov Disord; 1996 May; 11(3):321-3. PubMed ID: 8723151
[TBL] [Abstract][Full Text] [Related]
17. The effect of coenzyme Q10 and vitamin E on the regeneration of skeletal muscles in pigs.
Otrocka-Domagała I; Rotkiewicz T; Karpińska J; Purzyńska-Pugacewicz A; Kasperowicz B; Mikołajczyk A; Babińska I
Pol J Vet Sci; 2004; 7(4):295-303. PubMed ID: 15633790
[TBL] [Abstract][Full Text] [Related]
18. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?
Seet RC; Lim EC; Tan JJ; Quek AM; Chow AW; Chong WL; Ng MP; Ong CN; Halliwell B
Antioxid Redox Signal; 2014 Jul; 21(2):211-7. PubMed ID: 24410614
[TBL] [Abstract][Full Text] [Related]
19. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma.
Karpińska J; Mikołuć B; Motkowski R; Piotrowska-Jastrzebska J
J Pharm Biomed Anal; 2006 Sep; 42(2):232-6. PubMed ID: 16765550
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective actions of coenzyme Q10 in Parkinson's disease.
Sharma S; Kheradpezhou M; Shavali S; El Refaey H; Eken J; Hagen C; Ebadi M
Methods Enzymol; 2004; 382():488-509. PubMed ID: 15047119
[No Abstract] [Full Text] [Related]
[Next] [New Search]
